Eli Lilly is going to $5,000 by around 2032. Which isn't absolutely insane in the grand scheme of things but it's worth realizing there's gonna be like no downside volatility. That's what potentially makes it a generational trade
Revenue will come from durable medicine subscriptions and the company will be massively profitable the entire time without having to tap into concerning debt or equity financing like the hyperscalers
Given that, I think you can basically lever this thing as much as you can humanly stomach, with as much of your net worth as you can stomach. not financial advice, be safe, i could be wrong, have fun !